Stuttering with sertraline.
Brewerton
T D
TD
Markowitz
J S
JS
Keller
S G
SG
Cochrane
C E
CE
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D003866:Depressive Disorder / Q000188:drug therapy; D005260:Female; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D020280:Sertraline; D013342:Stuttering / Q000139:chemically induced*
D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline